Fda Approval Calendar 2018

FDA Approves Clinical Decision Support Tool for Stroke - Neurology

FDA Approves Clinical Decision Support Tool for Stroke - Neurology

Synergy Pharmaceuticals Announces FDA Approval of TRULANCE

Synergy Pharmaceuticals Announces FDA Approval of TRULANCE

FDA approves psychoactive psilocybin therapy trial for treatment

FDA approves psychoactive psilocybin therapy trial for treatment

US FDA approves Sun Pharma's Cequa to treat dry eye disease

US FDA approves Sun Pharma's Cequa to treat dry eye disease

FDA approval of oncology drug indications, 1949-2015 | Managed Care

FDA approval of oncology drug indications, 1949-2015 | Managed Care

The 510(k) Review Clock and How to Optimize Your Clearance Timeline

The 510(k) Review Clock and How to Optimize Your Clearance Timeline

FDA Approves More Generic Drugs, but Competition Still Lags | The

FDA Approves More Generic Drugs, but Competition Still Lags | The

The Non-Scientist's Guide to Clinical Trials - Endpoints | A Science

The Non-Scientist's Guide to Clinical Trials - Endpoints | A Science

FDA approved the first-ever generic version of EpiPen - STAT

FDA approved the first-ever generic version of EpiPen - STAT

FDA approves 9 generic versions of nerve pain drug Lyrica | ABC27

FDA approves 9 generic versions of nerve pain drug Lyrica | ABC27

FDA Revisions on Formal Meetings between FDA and Sponsors of PDUFA

FDA Revisions on Formal Meetings between FDA and Sponsors of PDUFA

FDA Drafts Guidance on Oncology Companion Diagnostics | RAPS

FDA Drafts Guidance on Oncology Companion Diagnostics | RAPS

FDA: Novartis knew of manipulation of data supporting Zolgensma approval

FDA: Novartis knew of manipulation of data supporting Zolgensma approval

08 - Approval of first 'RNA interference' drug – Why the excitement

08 - Approval of first 'RNA interference' drug – Why the excitement

Rare Cancers Are No Longer Orphans – OBR

Rare Cancers Are No Longer Orphans – OBR

Biotech Superstar Taking off After FDA Approval of Key Drug

Biotech Superstar Taking off After FDA Approval of Key Drug

FDA approves Benlysta for children, teens with lupus

FDA approves Benlysta for children, teens with lupus

FDA set an all-time record of new drug approvals in 2018

FDA set an all-time record of new drug approvals in 2018

FDA Approves Truvada-Like HIV Tablet Temixys - POZ

FDA Approves Truvada-Like HIV Tablet Temixys - POZ

US FDA Approval Actions To Watch Out For In June :: Pink Sheet

US FDA Approval Actions To Watch Out For In June :: Pink Sheet

Despite hemp legalization, FDA will still consider CBD products

Despite hemp legalization, FDA will still consider CBD products

FDA roundup: The major device, app, and algorithm approvals of 2018

FDA roundup: The major device, app, and algorithm approvals of 2018

Biotech Stocks Trading - Spotting Catalyst Events - RagingBull

Biotech Stocks Trading - Spotting Catalyst Events - RagingBull

Ron Reblando on Twitter:

Ron Reblando on Twitter: "$GERN #imetelstat -- #FDA

Moffitt Research Moves New Immunotherapy Closer to FDA Approval

Moffitt Research Moves New Immunotherapy Closer to FDA Approval

The Next Phase of Human Gene-Therapy Oversight | NEJM

The Next Phase of Human Gene-Therapy Oversight | NEJM

NCPDP Dates Associated with Pharmaceutical Products White Paper

NCPDP Dates Associated with Pharmaceutical Products White Paper

FDA permits marketing for controversial

FDA permits marketing for controversial "pregnancy prevention" app

EyePoint Pharmaceuticals Receives FDA Approval of YUTIQ

EyePoint Pharmaceuticals Receives FDA Approval of YUTIQ

Biotech Stocks Trading - Spotting Catalyst Events - RagingBull

Biotech Stocks Trading - Spotting Catalyst Events - RagingBull

Attention Biotech Investors: Mark Your Calendar For These October

Attention Biotech Investors: Mark Your Calendar For These October

Prescription Drug User Fee Act Reauthorization (PDUFA VI), Medical

Prescription Drug User Fee Act Reauthorization (PDUFA VI), Medical

10 Major Drugs Losing Patent Protections in 2018

10 Major Drugs Losing Patent Protections in 2018

Why marijuana is headed for the mainstream | Managed Care magazine

Why marijuana is headed for the mainstream | Managed Care magazine

First generics of Lyrica receive FDA approval

First generics of Lyrica receive FDA approval

The need for distinct nomenclature for originator and biosimilar

The need for distinct nomenclature for originator and biosimilar

FDA approves painkiller 1,000 times more powerful than morphine

FDA approves painkiller 1,000 times more powerful than morphine

Prescription Drug User Fee Act Reauthorization (PDUFA VI), Medical

Prescription Drug User Fee Act Reauthorization (PDUFA VI), Medical

Lachman Consultants Blog | News | Articles | Lachman Consultants

Lachman Consultants Blog | News | Articles | Lachman Consultants

FDA Calendar of Biotech Stock Catalysts • BioPharmCatalyst

FDA Calendar of Biotech Stock Catalysts • BioPharmCatalyst

Implantable System for Remodulin FDA Approved to Treat Pulmonary

Implantable System for Remodulin FDA Approved to Treat Pulmonary

Chart: Are Nevada cannabis sales beginning to plateau?

Chart: Are Nevada cannabis sales beginning to plateau?

Office of Generic Drugs Updates First Generic Approvals List for

Office of Generic Drugs Updates First Generic Approvals List for

FDA approves 19 new cancer drugs and biologics in 2018—and don't

FDA approves 19 new cancer drugs and biologics in 2018—and don't

3 Big 2019 FDA Decisions And Their Effect On These Biotechs

3 Big 2019 FDA Decisions And Their Effect On These Biotechs

July 2018 Record High Month for Generic Drug Approvals – Policy

July 2018 Record High Month for Generic Drug Approvals – Policy

FDA Calendar of new upcoming and establoshed BioTech Stock Companies

FDA Calendar of new upcoming and establoshed BioTech Stock Companies

Catalent-made Lucemyra wins US FDA approval for opioid withdrawal

Catalent-made Lucemyra wins US FDA approval for opioid withdrawal

RJ Health Systems Monthly Specialty FDA Actions (PDUFA Dates

RJ Health Systems Monthly Specialty FDA Actions (PDUFA Dates

Synergy Pharmaceuticals Announces FDA Approval of TRULANCE

Synergy Pharmaceuticals Announces FDA Approval of TRULANCE

ViiV Seeks FDA Approval for Two-Drug HIV Treatment - POZ

ViiV Seeks FDA Approval for Two-Drug HIV Treatment - POZ

Indian drugmakers under FDA radar as the US regulator approves more AN

Indian drugmakers under FDA radar as the US regulator approves more AN

A timeline of antiepileptic drugs  Date of US FDA approval unless

A timeline of antiepileptic drugs Date of US FDA approval unless

FDA Approval Times Best Those of Comparable International Agencies

FDA Approval Times Best Those of Comparable International Agencies

New drug wins FDA approval to treat chronic migraines

New drug wins FDA approval to treat chronic migraines

The Final Score: 2018 Drug & Biologic Patent Approvals | Dilworth IP

The Final Score: 2018 Drug & Biologic Patent Approvals | Dilworth IP

Rosenman D-Series: Tony Fields

Rosenman D-Series: Tony Fields "The Full Picture: Why FDA Approval

Magtrace Nanoparticles for Sentimag System is FDA Approved for

Magtrace Nanoparticles for Sentimag System is FDA Approved for

2019 PDA/FDA Joint Regulatory Conference

2019 PDA/FDA Joint Regulatory Conference

2017 in review: FDA approvals of new molecular entities - ScienceDirect

2017 in review: FDA approvals of new molecular entities - ScienceDirect

Evolus: US FDA validates troubled CMO site, but rejects BOTOX

Evolus: US FDA validates troubled CMO site, but rejects BOTOX

FDA Will Allow Observational Studies to Support Effectiveness

FDA Will Allow Observational Studies to Support Effectiveness

Breast Implants That May Cause Cancer-- The FDA's Meeting About

Breast Implants That May Cause Cancer-- The FDA's Meeting About

Women who sell Monat products posted false claims of FDA approval

Women who sell Monat products posted false claims of FDA approval

Patents will expire on these medications in 2018 - MedCity News

Patents will expire on these medications in 2018 - MedCity News

FDA Approves Marketing of 2 Devices to Detect Parathyroid Tissue in

FDA Approves Marketing of 2 Devices to Detect Parathyroid Tissue in

State Laws and Legislation Related to Biologic Medications and

State Laws and Legislation Related to Biologic Medications and

Fresh from the biotech pipeline—2018 | Nature Biotechnology

Fresh from the biotech pipeline—2018 | Nature Biotechnology

FDA approves IL-23 antagonist for plaque psoriasis – PM360

FDA approves IL-23 antagonist for plaque psoriasis – PM360

Drugs, Devices, and the FDA: Part 2: An Overview of Approval

Drugs, Devices, and the FDA: Part 2: An Overview of Approval

The need for distinct nomenclature for originator and biosimilar

The need for distinct nomenclature for originator and biosimilar

Drug Development & Delivery - The Latest Methods in Drug Development

Drug Development & Delivery - The Latest Methods in Drug Development

Despite Warnings, FDA Approves Potent New Opioid Painkiller | KPBS

Despite Warnings, FDA Approves Potent New Opioid Painkiller | KPBS

Drug pipeline: 2Q18 | Nature Biotechnology

Drug pipeline: 2Q18 | Nature Biotechnology

Watch These Biotechs and the FDA Calendar - RealMoney

Watch These Biotechs and the FDA Calendar - RealMoney

Akcea and Ionis Receive FDA Approval of TEGSEDI™ (inotersen) for the

Akcea and Ionis Receive FDA Approval of TEGSEDI™ (inotersen) for the

First FDA-approved cannabis-based drug now available in the US

First FDA-approved cannabis-based drug now available in the US

What New Treatments Are on the Horizon for Hepatitis B/D Coinfected

What New Treatments Are on the Horizon for Hepatitis B/D Coinfected

The FDA just rejected Allergan's women's health drug (AGN) | Markets

The FDA just rejected Allergan's women's health drug (AGN) | Markets

Patent Docs: Status of U S  Biosimilar Approvals and Pending

Patent Docs: Status of U S Biosimilar Approvals and Pending

Biotech Stocks Trading - Spotting Catalyst Events - RagingBull

Biotech Stocks Trading - Spotting Catalyst Events - RagingBull

FDA approves new painkiller, discusses future consideration of new

FDA approves new painkiller, discusses future consideration of new